Pasar al contenido principal

MODIFICACION DE PROTEINAS POR LIPOXIDACION Y ADICION DE FARMACOS: NUEVAS PERSPECTIVAS EN EL ESTUDIO DE LOS MECANISMOS DE LA ENFERMEDAD Y EL DISEÑO DE ESTRATEGIAS TERAPEUTICAS

SAF2015-68590-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2015
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Dirección General de Investigación Científica y Técnica
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Alterations in nucleocytoplasmic localization of the methionine cycle induced by oxidative stress during liver disease

  • Pérez-Sala, Dolores
  • Martínez-Costa, Oscar H.
  • Aragón, Juan J.
  • Pajares, María Ángeles
21 p.-5 fig.-2 tab. (Chapter 3), Homeostasis of the main cellular methyl donor, S-adenosylmethionine, depends on the methionine cycle, which is at the crossroads of metabolic pathways involved in the synthesis and regulation of a large variety of compounds and processes. Impairment of the methionine cycle is detected in a vast majority of liver diseases that concur with oxidative stress. The complex regulation of the pathway is exerted from transcriptional to protein oligomerization and activity levels, subcellular distribution being recently added to the play. Oxidative stress performs a role at all of these regulatory levels either directly (e.g., eliciting protein modifications) or indirectly (e.g., decreasing recycling of vitamin B12). Therefore, the interest in deciphering the mechanisms through which medical interventions could revert methionine cycle impairment, contributing to liver disease treatment. In this line, the control of subcellular distribution has emerged as a putative target for new and existent antioxidants, their evaluation requiring a large research effort., Work carried out in the author’s laboratories was supported by grants of the Ministerio de Economía y Competitividad (BFU2009-08977 to MAP; SAF2012-36519 and SAF2015-68590-R to DPS), Peer reviewed